| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/19/2003 | EP1283885A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/19/2003 | EP1283884A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 02/19/2003 | EP1283882A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 02/19/2003 | EP1283878A2 Receptor-based interaction trap |
| 02/19/2003 | EP1283874A2 Novel deoxynucleoside kinase enzyme variants |
| 02/19/2003 | EP1283871A2 Production of dendritic cells from bone-marrow stem cells |
| 02/19/2003 | EP1283869A2 Novel bee venom polypeptides and methods of use thereof |
| 02/19/2003 | EP1283868A2 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof |
| 02/19/2003 | EP1283849A2 Human receptor proteins; related reagents and methods |
| 02/19/2003 | EP1283848A2 Protein complexes and assays for screening anti-cancer agents |
| 02/19/2003 | EP1283726A2 Dendritic cells loaded with toxic substances |
| 02/19/2003 | EP1283721A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/19/2003 | EP1283670A2 Microinjection of cryoprotectants for preservation of cells |
| 02/19/2003 | EP1283668A1 Nucleic acids that control plant development |
| 02/19/2003 | EP1056777A4 Ligand receptors and uses therefor |
| 02/19/2003 | EP0850073B1 Inhibition of vascular occlusion following vascular intervention |
| 02/19/2003 | CN1398299A BZIP type transcripton factors regulating expression of rice storage protein |
| 02/19/2003 | CN1398298A Non-endogenous, constitutively activated human G protein-coupled receptors |
| 02/19/2003 | CN1398297A Recombinant flaviviruses and methods of use thereof |
| 02/19/2003 | CN1397646A Process for cloning myocardial cell, heart tissue and heart |
| 02/19/2003 | CN1397640A Stem cell, and its preparing process and usage |
| 02/19/2003 | CN1397532A Culture liquid for rescue culture and seedling culture of disease-resistant non-kernel grape buds |
| 02/19/2003 | CN1101695C Application of medicine from plant extracts for treatment of increase bone resorption, and compsns, thereof |
| 02/18/2003 | US6521816 Nucleic acid molecules from rice and their use for the production of modified starch |
| 02/18/2003 | US6521750 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 02/18/2003 | US6521749 GL50 nucleic acids and uses therefor |
| 02/18/2003 | US6521737 Peptides which enhance transport across tissues and methods of identifying and using the same |
| 02/18/2003 | US6521598 Peptide consisting of an amino acid sequence 1: SPSVDKARAEL; induces transplant tolerance |
| 02/18/2003 | US6521457 Lentivirus-based gene transfer vectors |
| 02/18/2003 | US6521455 Viral polypeptide for use as tool in genetic engineering and gene therapy |
| 02/18/2003 | US6521452 Somatic embryos produced from explant; encapsulation to produce artificial seeds |
| 02/18/2003 | US6521450 Cells expressing a modified regulator of complement activation |
| 02/18/2003 | US6521442 Polynucleotide compositions encoding broad spectrum δ-endotoxins |
| 02/18/2003 | US6521441 Staphylococcus aureus genes and polypeptides |
| 02/18/2003 | US6521437 Human sphingosine lyase polypeptides |
| 02/18/2003 | US6521436 Gene expression; drug screening for antiarthritic agents; bone disorders |
| 02/18/2003 | US6521422 Fhm, a novel member of the TNF ligand supergene family |
| 02/18/2003 | US6521419 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| 02/18/2003 | US6521415 Tandem immuno-assay for cancer |
| 02/18/2003 | US6521413 Bioassay; monitoring cells for changes in ion channel activity |
| 02/18/2003 | US6521412 Drug screening for anticarcinogenic agents and agents to treat atherosclerosis and neurodegenerative disorders |
| 02/18/2003 | US6521406 From Saccharopolyspora; genetic engineering |
| 02/18/2003 | US6521403 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue |
| 02/18/2003 | US6521248 Cavitation; reduced pressure; oxygenated water |
| 02/18/2003 | US6521236 Vector vaccine of recombinant feline herpesvirus |
| 02/18/2003 | US6521235 Alphavirus RNA replicon systems |
| 02/18/2003 | US6521230 CD25 binding molecules |
| 02/18/2003 | US6519954 Cryogenic preservation of biologically active material using high temperature freezing |
| 02/18/2003 | US6519953 Method for use of latent heat to maintain selectable cold storage temperatures |
| 02/18/2003 | CA2071211C Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products |
| 02/13/2003 | WO2003012449A2 Method for selecting antibody expressing cells |
| 02/13/2003 | WO2003012441A1 Method for detecting modulators of notch signalling |
| 02/13/2003 | WO2003012394A2 Androgen receptor knock-out transgenic animals |
| 02/13/2003 | WO2003012393A2 Method of detecting protease activity in a cell |
| 02/13/2003 | WO2003012143A1 Genes and snps associated with eating disorders |
| 02/13/2003 | WO2003012126A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 02/13/2003 | WO2003012112A1 Methylation resistant vectors |
| 02/13/2003 | WO2003012111A2 Conjugates for the modulation of immune responses |
| 02/13/2003 | WO2003012105A2 Vegf isoform |
| 02/13/2003 | WO2003012104A1 Novel g protein-coupled receptor protein and dna thereof |
| 02/13/2003 | WO2003012099A1 Chondroitin synthase |
| 02/13/2003 | WO2003012089A2 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof |
| 02/13/2003 | WO2003012086A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 02/13/2003 | WO2003012085A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 02/13/2003 | WO2003012084A2 Human glucose-dependent insulin-secreting cell line |
| 02/13/2003 | WO2003012083A1 In vitro reconstituted sheets of human corneal epithelium and method of producing the same |
| 02/13/2003 | WO2003012082A2 Method for modulating stem cell differentiation using stem loop rna |
| 02/13/2003 | WO2003012081A1 Generation of fully mature and stable dendritic cells from leukaphereses products for clinical applications |
| 02/13/2003 | WO2003012080A2 Ex-vivo selection of t-cells with reduced alloreactivity and use thereof in bone marrow transplantations |
| 02/13/2003 | WO2003012079A1 High-density cell culture method and culture apparatus using apatite sheet and cell culture module |
| 02/13/2003 | WO2003012078A2 Dendritic cells and the uses thereof in screening cellular targets and potential drugs |
| 02/13/2003 | WO2003012077A1 Method for preventing the adhesion of particles |
| 02/13/2003 | WO2003012076A2 Culture medium to improve the purity of myoblast cultures and method using same |
| 02/13/2003 | WO2003012069A2 Compositions and methods for generating chimeric heteromultimers |
| 02/13/2003 | WO2003012068A2 Novel fusion proteins and assays for molecular binding |
| 02/13/2003 | WO2003012062A2 Animal model with disrupted fgf14 gene |
| 02/13/2003 | WO2003012061A2 Methods and compositions relating to plasmacytoid dendritic cells |
| 02/13/2003 | WO2003012060A2 Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd |
| 02/13/2003 | WO2003012058A2 Media and methods for cultivation of microorganisms |
| 02/13/2003 | WO2003012056A2 Carotenoid ketolase gene |
| 02/13/2003 | WO2003012054A2 Methods and compositions relating to improved lentiviral vector production systems |
| 02/13/2003 | WO2003012049A2 Methods and composition concerning herpes virus us3 and bad-involved apoptosis |
| 02/13/2003 | WO2003012045A2 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 02/13/2003 | WO2003012044A2 Hagfish cathelin-associated antimicrobial peptides and genes |
| 02/13/2003 | WO2003012041A2 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit |
| 02/13/2003 | WO2003012029A2 Method for selective enhancement of cell growth |
| 02/13/2003 | WO2003011924A1 Polymer for coating leukocyte removal filter material and the filter material |
| 02/13/2003 | WO2003011899A2 Antigenic polypeptides |
| 02/13/2003 | WO2003011893A2 Immunologically significant herpes simplex virus antigens and methods for using same |
| 02/13/2003 | WO2003011878A2 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 02/13/2003 | WO2003011451A1 Cell isolation and screening device and method of using same |
| 02/13/2003 | WO2003011369A1 Device for and method of controlled enzymatic removal and retrieval of tissue |
| 02/13/2003 | WO2003011343A1 Method of regenerating bone/chondral tissues by transferring transcriptional factor gene |
| 02/13/2003 | WO2003011330A1 Membrane vesicles of biological fluid sampled in vivo, their preparation and use in stimulating an immune response |
| 02/13/2003 | WO2003011317A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | WO2003011313A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 02/13/2003 | WO2003011304A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity |
| 02/13/2003 | WO2003011230A2 Modified reoviral therapy |
| 02/13/2003 | WO2003011219A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/13/2003 | WO2003011209A2 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes |